A two-stage, genome-wide screen for susceptibility loci in primary Raynaud's phenomenon

Arthritis Rheum. 2000 Jul;43(7):1641-6. doi: 10.1002/1529-0131(200007)43:7<1641::AID-ANR30>3.0.CO;2-Y.

Abstract

Objective: To identify chromosomal regions containing genes involved in the susceptibility to primary Raynaud's phenomenon (RP).

Methods: Six extended families with multiple individuals affected with primary RP (n = 37) were examined for linkage in a 2-stage, whole-genome screen, using a total of 298 microsatellite markers.

Results: Multipoint, nonparametric linkage analysis identified 5 areas of possible linkage, with a nominal level of significance of P < or = 0.05. Analysis of a finer map of markers in these regions defined the regions of linkage as 21.4 cM on 6q13-6q23.3 (D6S261; P = 0.0004), 10.2 cM on 7p22-7p15 (D7S664; P = 0.014), 1.6 cM on 9p23-9p22 (D9S156; P = 0.0075), 5.1 cM on 17p13.1-17p12 (D17S1791; P = 0.036), and 11.8 cM on Xp11.4-Xp11.23 (DXS8054; P = 0.006). Three potential candidate genes map to these regions: the beta subunit of the muscle acetylcholine receptor and the serotonin 1B and 1E receptors.

Conclusion: These results provide evidence of the presence and location of genes that are involved in the genetic susceptibility to primary RP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Chromosome Mapping
  • DNA / analysis
  • Female
  • Genetic Linkage
  • Genetic Predisposition to Disease*
  • Genetic Testing / methods*
  • Genome, Human*
  • Humans
  • Infant
  • Male
  • Microsatellite Repeats
  • Pedigree
  • Raynaud Disease / classification
  • Raynaud Disease / genetics*
  • Receptor, Serotonin, 5-HT1B
  • Receptors, Cholinergic / genetics
  • Receptors, Serotonin / genetics

Substances

  • HTR1B protein, human
  • Receptor, Serotonin, 5-HT1B
  • Receptors, Cholinergic
  • Receptors, Serotonin
  • serotonin 1E receptor
  • DNA